BKHA
NASDAQBlack Hawk Acquisition Corporation
Price$11.65+0.16 (+1.39%)
2026-03-042026-06-05
News · 26 weeks15-100%
2025-12-142026-06-07
Mix890d
- SEC Filings6(75%)
- Leadership1(13%)
- Other1(13%)
Latest news
25 items- SECBlack Hawk Acquisition Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Financial Statements and Exhibits8-K - Black Hawk Acquisition Corp (0002000775) (Filer)
- SECAmendment: SEC Form S-4/A filed by Black Hawk Acquisition CorporationS-4/A - Black Hawk Acquisition Corp (0002000775) (Filer)
- SECAmendment: SEC Form 10-K/A filed by Black Hawk Acquisition Corporation10-K/A - Black Hawk Acquisition Corp (0002000775) (Filer)
- SECSEC Form 10-Q filed by Black Hawk Acquisition Corporation10-Q - Black Hawk Acquisition Corp (0002000775) (Filer)
- SECSEC Form NT 10-Q filed by Black Hawk Acquisition CorporationNT 10-Q - Black Hawk Acquisition Corp (0002000775) (Filer)
- SECBlack Hawk Acquisition Corporation filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing8-K - Black Hawk Acquisition Corp (0002000775) (Filer)
- PRVesicor Therapeutics Appoints Michael Tolentino, M.D., as Chief Executive OfficerBLACKHAWK, Calif., March 18, 2026 (GLOBE NEWSWIRE) -- Vesicor Therapeutics, Inc., a San Gabriel, California-based early development stage biotechnology corporation focused on the development of p53-based cancer therapeutics delivered via precision-engineered microvesicles and a proposed de-SPAC acquisition target for Black Hawk Acquisition Corporation (NASDAQ:BKHA, BKHAU, BKHAR)), today announced that its Board of Directors has appointed Michael Tolentino, M.D., an accomplished biotech leader with deep industry experience, as Chief Executive Officer (CEO), effective March 17, 2026. He succeeds Founder and CEO Luo Feng, Ph.D., who has been appointed Chief Scientific Officer. "Dr. Tolentino
- SECBlack Hawk Acquisition Corporation filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Black Hawk Acquisition Corp (0002000775) (Filer)
- SECSEC Form 10-K filed by Black Hawk Acquisition Corporation10-K - Black Hawk Acquisition Corp (0002000775) (Filer)
- SECSEC Form NT 10-K filed by Black Hawk Acquisition CorporationNT 10-K - Black Hawk Acquisition Corp (0002000775) (Filer)
- SECBlack Hawk Acquisition Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Financial Statements and Exhibits8-K - Black Hawk Acquisition Corp (0002000775) (Filer)
- SECBlack Hawk Acquisition Corporation filed SEC Form 8-K: Leadership Update8-K - Black Hawk Acquisition Corp (0002000775) (Filer)
- SECAmendment: SEC Form S-4/A filed by Black Hawk Acquisition CorporationS-4/A - Black Hawk Acquisition Corp (0002000775) (Filer)
- SECSEC Form DEL AM filed by Black Hawk Acquisition CorporationDEL AM - Black Hawk Acquisition Corp (0002000775) (Filer)
- SECSEC Form S-4 filed by Black Hawk Acquisition CorporationS-4 - Black Hawk Acquisition Corp (0002000775) (Filer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Black Hawk Acquisition CorporationSCHEDULE 13G/A - Black Hawk Acquisition Corp (0002000775) (Subject)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Black Hawk Acquisition CorporationSCHEDULE 13G/A - Black Hawk Acquisition Corp (0002000775) (Subject)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Black Hawk Acquisition CorporationSCHEDULE 13G/A - Black Hawk Acquisition Corp (0002000775) (Subject)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Black Hawk Acquisition CorporationSCHEDULE 13G/A - Black Hawk Acquisition Corp (0002000775) (Subject)
- SECSEC Form 10-Q filed by Black Hawk Acquisition Corporation10-Q - Black Hawk Acquisition Corp (0002000775) (Filer)
- SECSEC Form NT 10-Q filed by Black Hawk Acquisition CorporationNT 10-Q - Black Hawk Acquisition Corp (0002000775) (Filer)
- SECSEC Form SCHEDULE 13G filed by Black Hawk Acquisition CorporationSCHEDULE 13G - Black Hawk Acquisition Corp (0002000775) (Subject)
- SECBlack Hawk Acquisition Corporation filed SEC Form 8-K: Other Events8-K - Black Hawk Acquisition Corp (0002000775) (Filer)
- SECBlack Hawk Acquisition Corporation filed SEC Form 8-K: Other Events8-K - Black Hawk Acquisition Corp (0002000775) (Filer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Black Hawk Acquisition CorporationSCHEDULE 13G/A - Black Hawk Acquisition Corp (0002000775) (Subject)
BKHA FAQ
5 questionsWhere does BKHA stock trade?
Black Hawk Acquisition Corporation (BKHA) is listed on NASDAQ.What sector and industry is BKHA in?
Black Hawk Acquisition Corporation operates in the Health Care sector, Biotechnology: Biological Products (No Diagnostic Substances) industry.When did Black Hawk Acquisition Corporation go public?
Black Hawk Acquisition Corporation (BKHA) completed its IPO in 2024.What companies are similar to BKHA?
Notable peers in the same industry include AMGN (Amgen Inc.), GILD (Gilead Sciences Inc.), ARGX (argenx SE), RVMD (Revolution Medicines Inc.), BIIB (Biogen Inc.). Compare BKHA side-by-side with any of them on Quantisnow.How can I track BKHA on Quantisnow?
Quantisnow aggregates Black Hawk Acquisition Corporation's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow BKHA to receive live email and push alerts on every new disclosure.